225 related articles for article (PubMed ID: 29316206)
1. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.
Kim TK; Park CS; Jang J; Kim MR; Na HJ; Lee K; Kim HJ; Heo K; Yoo BC; Kim YM; Lee JW; Kim SJ; Kim ES; Kim DY; Cha K; Lee TG; Lee S
Mol Oncol; 2018 Mar; 12(3):356-372. PubMed ID: 29316206
[TBL] [Abstract][Full Text] [Related]
2. Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.
Ki MK; Jeoung MH; Choi JR; Rho SS; Kwon YG; Shim H; Chung J; Hong HJ; Song BD; Lee S
Oncogene; 2013 Nov; 32(48):5449-57. PubMed ID: 23644659
[TBL] [Abstract][Full Text] [Related]
3. CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis.
Jang J; Kim MR; Kim TK; Lee WR; Kim JH; Heo K; Lee S
Sci Rep; 2017 Sep; 7(1):10666. PubMed ID: 28878328
[TBL] [Abstract][Full Text] [Related]
4. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
5. Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth.
Noy PJ; Lodhia P; Khan K; Zhuang X; Ward DG; Verissimo AR; Bacon A; Bicknell R
Oncogene; 2015 Nov; 34(47):5821-31. PubMed ID: 25745997
[TBL] [Abstract][Full Text] [Related]
6. Clec14a genetically interacts with Etv2 and Vegf signaling during vasculogenesis and angiogenesis in zebrafish.
Pociute K; Schumacher JA; Sumanas S
BMC Dev Biol; 2019 Apr; 19(1):6. PubMed ID: 30953479
[TBL] [Abstract][Full Text] [Related]
7. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).
Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R
FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791
[TBL] [Abstract][Full Text] [Related]
8. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.
Zhuang X; Maione F; Robinson J; Bentley M; Kaul B; Whitworth K; Jumbu N; Jinks E; Bystrom J; Gabriele P; Garibaldi E; Delmastro E; Nagy Z; Gilham D; Giraudo E; Bicknell R; Lee SP
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 33004686
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
10. Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion.
Rho SS; Choi HJ; Min JK; Lee HW; Park H; Park H; Kim YM; Kwon YG
Biochem Biophys Res Commun; 2011 Jan; 404(1):103-8. PubMed ID: 21095181
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG
J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863
[TBL] [Abstract][Full Text] [Related]
12. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
13. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.
Kim DG; Jin Y; Jin J; Yang H; Joo KM; Lee WS; Shim SR; Kim SW; Yoo J; Lee SH; Yoo JS; Nam DH
MAbs; 2015; 7(6):1195-204. PubMed ID: 26325365
[TBL] [Abstract][Full Text] [Related]
15. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
16. Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.
Mura M; Swain RK; Zhuang X; Vorschmitt H; Reynolds G; Durant S; Beesley JF; Herbert JM; Sheldon H; Andre M; Sanderson S; Glen K; Luu NT; McGettrick HM; Antczak P; Falciani F; Nash GB; Nagy ZS; Bicknell R
Oncogene; 2012 Jan; 31(3):293-305. PubMed ID: 21706054
[TBL] [Abstract][Full Text] [Related]
17. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth.
Lamagna C; Hodivala-Dilke KM; Imhof BA; Aurrand-Lions M
Cancer Res; 2005 Jul; 65(13):5703-10. PubMed ID: 15994945
[TBL] [Abstract][Full Text] [Related]
18. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
20. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
